These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11086057)

  • 21. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V; Höllsberg P
    J Med Virol; 2004 Apr; 72(4):635-45. PubMed ID: 14981767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR; Khanna R; Burrows JM; Moss DJ
    J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.
    Hausmann S; Biddison WE; Smith KJ; Ding YH; Garboczi DN; Utz U; Wiley DC; Wucherpfennig KW
    J Immunol; 1999 May; 162(9):5389-97. PubMed ID: 10228016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A broad cytotoxic T lymphocyte response to influenza type B virus presented by multiple HLA molecules.
    Robbins PA; Rota PA; Shapiro SZ
    Int Immunol; 1997 Jun; 9(6):815-23. PubMed ID: 9199964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competitive inhibition in vivo and skewing of the T cell repertoire of antigen-specific CTL priming by an anti-peptide-MHC monoclonal antibody.
    Chung DH; Belyakov IM; Derby MA; Wang J; Boyd LF; Berzofsky JA; Margulies DH
    J Immunol; 2001 Jul; 167(2):699-707. PubMed ID: 11441073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I.
    Chen ZW; Craiu A; Shen L; Kuroda MJ; Iroku UC; Watkins DI; Voss G; Letvin NL
    J Immunol; 2000 Jun; 164(12):6474-9. PubMed ID: 10843704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetramer binding and secretion of interferon-gamma in response to antigenic stimulation are compatible with a range of affinities of MHC:TCR interaction and distinct programs of cytotoxic T-lymphocyte activation.
    Wei CH; Uhlin M; Masucci MG; Levitsky V
    Hum Immunol; 2002 Oct; 63(10):821-33. PubMed ID: 12368034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex.
    Brooks JM; Colbert RA; Mear JP; Leese AM; Rickinson AB
    J Immunol; 1998 Nov; 161(10):5252-9. PubMed ID: 9820497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity.
    Sandberg JK; Franksson L; Sundbäck J; Michaelsson J; Petersson M; Achour A; Wallin RP; Sherman NE; Bergman T; Jörnvall H; Hunt DF; Kiessling R; Kärre K
    J Immunol; 2000 Jul; 165(1):25-33. PubMed ID: 10861031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V; Zhang QJ; Levitskaya J; Masucci MG
    J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
    Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
    J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR; Silins SL; Moss DJ; Khanna R; Misko IS; Argaet VP
    J Exp Med; 1995 Dec; 182(6):1703-15. PubMed ID: 7500015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.
    Denkberg G; Cohen CJ; Reiter Y
    J Immunol; 2001 Jul; 167(1):270-6. PubMed ID: 11418659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.
    Boon AC; de Mutsert G; van Baarle D; Smith DJ; Lapedes AS; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Immunol; 2004 Feb; 172(4):2453-60. PubMed ID: 14764717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL.
    Wilson CS; Moser JM; Altman JD; Jensen PE; Lukacher AE
    J Immunol; 1999 Apr; 162(7):3933-41. PubMed ID: 10201912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.
    Andersen MH; Bonfill JE; Neisig A; Arsequell G; Sondergaard I; Valencia G; Neefjes J; Zeuthen J; Elliott T; Haurum JS
    J Immunol; 1999 Oct; 163(7):3812-8. PubMed ID: 10490979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.
    Khanna R; Burrows SR; Nicholls J; Poulsen LM
    Eur J Immunol; 1998 Feb; 28(2):451-8. PubMed ID: 9521052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited diversity of peptides related to an alloreactive T cell epitope in the HLA-B27-bound peptide repertoire results from restrictions at multiple steps along the processing-loading pathway.
    Paradela A; Alvarez I; García-Peydró M; Sesma L; Ramos M; Vázquez J; López De Castro JA
    J Immunol; 2000 Jan; 164(1):329-37. PubMed ID: 10605027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR.
    Dutoit V; Rubio-Godoy V; Doucey MA; Batard P; Liénard D; Rimoldi D; Speiser D; Guillaume P; Cerottini JC; Romero P; Valmori D
    J Immunol; 2002 Feb; 168(3):1167-71. PubMed ID: 11801651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.